Corticotropin releasing factor receptors and their ligand family

Annals of the New York Academy of Sciences

Volumn 885, Issue , 1999, Pages 312-328

  Perrin, Marilyn H ^a   Vale, Wylie W ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; CORTICOTROPIN RELEASING FACTOR RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; MESSENGER RNA; UROCORTIN;

ALTERNATIVE RNA SPLICING; BINDING AFFINITY; BRAIN; CONFERENCE PAPER; ENZYME ACTIVATION; GONAD; HEART MUSCLE; HOMEOSTASIS; HUMAN; HYPOPHYSIS; LYMPHOCYTE; MOLECULAR CLONING; MUTAGENESIS; NONHUMAN; RECEPTOR GENE; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; SKIN; TISSUE DISTRIBUTION;

EID: 0032801846     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb08687.x     Document Type: Conference Paper

References (72)

1. 1. Torpy, D.J. & G.P. Chrousos. 1996. The three-way interactions between the hypothalamic-pituitary-adrenal and gonadal axes and the immune system. Baillieres Clin. Rheumatol. 10: 181-198.
2. 2. Richter, R.M. & M.J. Mulvany. 1995. Comparison of hCRF and oCRF effects on cardiovascular responses after central, peripheral, and in vitro application. Peptides 16: 843-849.
3. 3. Fisher, L.A. 1993. Central actions of corticotropin-releasing factor on autonomic nervous activity and cardiovascular functioning. Ciba Found. Symp. 172: 243-253.
4. 4. Nemeroff, C.B., E. Widerlov, G. Bissette et al. 1984. Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivily in depressed patients. Science 226: 1342-1344.
5. 5. Plotsky, P.M., M.J. Owens & C.B. Nemeroff. 1998. Psychoneuroendocrinology of depression. Hypothalamic-pituitary-adrenal axis. Psychiatr. Clin. North Am. 21: 293-307.
6. 6. Nasman, B., T. Olsson, M. Fagerlund et al. 1996. Blunted adrenocorticotropin and increased adrenal steroid response to human corticotropin-releasing hormone in Alzheimer's disease. Biol. Psychiatry. 39: 311-318.
7. 7. Behan, D.P., S.C. Heinrichs, J.C. Troncoso et al. 1995. Displacement of corticotropin releasing factor from its binding protein as a possible treatment for Alzheimer's disease. Nature 378: 284-287.
8. 8. Raadsheer, F.C., J.J. Van Heerikhutze, P.J. Lucassen et al. 1995. Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression. Am. J. Psychiatry 152: 1372-1376.
9. 9. Eagles, E., G. Santilli, A. Okosi et al. 1998. Endogenous corticotropin releasing hormone protects neuroblastoma cells from hypoxia-induced necrosis. (Abst. # P1-420). In Endocrine Soc. Meeting, June 1988, New Orleans, Louisiana.
10. 10. Tjuvajev, J., Y. Kolesnikov, R. Joshi et al. 1998. Anti-neoplastic properties of human corticotropin releasing factor: involvement of the nitric oxide pathway. In Vivo 12: 1-10.
11. 11. Moody, T.W., F. Zia, R. Venugopal et al. 1994. Corticotropin-releasing factor stimulates cyclic AMP, arachidonic acid release, and growth of lung cancer cells. Peptides 15: 281-285.
12. 12. Chen, R., K.A. Lewis, M.H. Perrin et al. 1993. Expression cloning of a human corticotropin-releasing factor receptor. Proc. Natl. Acad. Sci. USA 90: 8967-8971.
13. 13. Vita, N., P. Laurent, S. Lefort et al. 1993. Primary structure and functional expression of mouse pituitary and human brain corticotrophin releasing factor receptors. FEBS Lett. 335: 1-5.
14. 14. Chang, C.-P., R.V. Pearse, II, S. O'Connell et al. 1993. Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain. Neuron 11: 1187-1195.
15. 15. Perrin, M.H., C.J. Donaldson, R. Chen et al. 1993. Cloning and functional expression of a rat brain corticotropin releasing factor (CRF) receptor. Endocrinology 133: 3058-3061.
16. 16. Yu, J., L.Y. Xie & A.-B. Abou-Samra. 1996. Molecular cloning of a type A chicken corticotropin-releasing factor receptor with high affinity for urotensin I. Endocrinology 137: 192-197.
17. 17. Dautzenberg, F.M., K. Dietrich, M.R. Palchaudhuri et al. 1997. Identification of two corticotropin-releasing factor receptors from Xenopus laevis with high ligand selectivity: unusual pharmacology of the type-I receptor. J. Neurochem. 69: 1640-1649.
18. 18. Ross, P.C., C.M. Kostas & T.V. Ramabhadran. 1994. A variant of the human corticotropin-releasing factor (CRF) receptor: cloning, expression and pharmacology. Biochem. Biophys. Res. Comm. 205: 1836-1842.
19. 19. Karteris, E., D. Grammatopoulos, Y. Dai et al. 1998. The human placenta and fetal membranes express the corticotropin-releasing hormone receptor 1alpha (CRH-1alpha) and the CRH-C variant receptor. J. Clin. Endocrinol. Metab. 83: 1376-1379.
20. 20. Tsai-Morris, C.H., E. Buczko, Y. Geng et al. 1996. The genomic structure of the rat corticotropin releasing factor receptor. J. Biol. Chem. 271: 14519-14525.
21. 21. De Souza, E.B., M.H. Perrin, T.R. Insel et al. 1984. Corticotropin-releasing factor receptors in rat forebrain: autoradiographic identification. Science 224: 1449-1451.
22. 22. Primus, R.J., W. Yevich, C. Baltazar et al. 1997. Autoradiographic localization of CRF1 and CRF2 binding sites in adult rat brain. Neuropsychopharmacology 17: 308-316.
23. 23. Potter, E., S. Sutton, C. Donaldson et al. 1994. Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. Proc. Natl. Acad. Sci. USA 91: 8777-8781.
24. 24. Chalmers, D.T., T.W. Lovenberg & E.B. DeSouza. 1995. Localization of novel corticotropin-releasing factor receptor (CRF2)mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J. Neurosci. 15: 6340-6350.
25. 25. Lovenberg, T.W., W.L. Chen, D.E. Grigoriadis et al. 1995. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc. Natl. Acad. Sci. USA 92: 836-840.
26. 26. Perrin, M., C. Donaldson, R. Chen et al. 1995. Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart. Proc. Natl. Acad. Sci. USA 92: 2969-2973.
27. 27. Kishimoto, T., R.V. Pearse II, C.R. Lin et al. 1995. A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle. Proc. Natl. Acad. Sci. USA 92: 1108-1112.
28. 28. Stenzel, P., R. Kesterson, W. Yeung et al. 1995. Identification of a novel murine receptor for corticotropin-releasing hormone expressed in the heart. Mol. Endocrinol. 9: 637-645.
29. 29. Liaw, C.W., T.W. Lovenberg, T. Oltersdorf et al. 1996. Cloning and characterization of the human corticotropin-releasing factor-2 receptor complementary deoxyribonucleic acid. Endocrinology 137: 72-77.
30. 30. Valdenaire, O., T. Giller, V. Breu et al. 1997. A new functional isoform of the human CRF2 receptor for corticotropin-releasing factor. Biochim. Biophys. Acta 1352: 129-132.
31. 31. Kostich, W.A., A. Chen, K. Sperle et al. 1998. Molecular identification and analysis of a novel human corticotropin-releasing factor (CRF) receptor: the CRF2gamma receptor. Mol. Endocrinol. 12: 1077-1085.
32. 32. Sakai, K., S. Nagafuchi, N. Horiba et al. 1998. The genomic organization of the human corticotropin-releasing factor type-1 receptor. (Abst. # P3-571). In Endocrine Soc. Meeting, June 1988, New Orleans, Louisiana.
33. 33. Heinrich, N., M.R. Meyer, J. Furkert et al. 1998. Corticotropin-releasing factor (CRF) agonists stimulate testosterone production in mouse leydig cells through CRF receptor-1. Endocrinology 139: 651-658.
34. 34. Asakura, H., I.H. Zwain & S.S. Yen. 1997. Expression of genes encoding corticotropin-releasing factor (CRF), type-1 CRF receptor, and CRF-binding protein and localization of the gene products in the human ovary. J. Clin. Endocrinol. Metab. 82: 2720-2725.
35. 35. Slominski, A., G. Ermak, J. Hwang et al. 1995. Proopiomelanocortin, corticotropin releasing hormone and corticotropin releasing hormone receptor genes are expressed in human skin. FEBS Lett. 374: 113-116.
36. 36. Ermak, G. & A. Slominski. 1997. Production of POMC, CRH-R1, MC1, and MC2 receptor mRNA and expression of tyrosinase gene in relation to hair cycle and dexamethasone treatment in the C57BL/6 mouse skin. J. Invest. Dermatol. 108: 160-165.
37. 37. DiBlasio, A.M., F.P. Giraldi, P. Vigano et al. 1997. Expression of corticotropin-releasing hormone and its R1 receptor in human endometrial stromal cells. J. Clin. Endocrinol. Metab. 82: 1594-1597.
38. 38. Theoharides, T.C., L.K. Singh, W. Boucher et al. 1998. Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects. Endocrinololgy 139: 403-413.
39. 39. Slominski, A., G. Ermak, J.E. Mazurkiewicz et al. 1998. Characterization of corticotropin-releasing hormone (CRH) in human skin. J. Clin. Endocrinol. Metab. 83: 1020-1024.
40. 40. Lovenberg, T.W., D.T. Chalmers, C. Liu et al. 1995. CRF2 alpha and CRF2 beta receptor mRNAs are differentially distributed between the rat central nervous system and peripheral tissues. Endocrinology 136: 4139-4142.
41. 41. Heldwein, K.A., D.L. Redick, M.B. Rittenberg et al. 1996. Corticotropin-releasing hormone receptor expression and functional coupling in neonatal cardiac myocytes and AT-1 cells. Endocrinology 137: 3631-3639.
42. 42. Rohde, E., J. Furkert, K. Fechner et al. 1996. Corticotropin-releasing hormone (CRH) receptors in the mesenteric small arteries of rats resemble the (2)-subtype. Biochem. Pharmacol. 52: 829-833.
43. 43. Okawara, Y., S.D. Morley, L.O. Burzio et al. 1988. Cloning and sequence analysis of cDNA for corticotropin-releasing factor precursor from the teleost fish Catostomus commersoni. Proc. Natl. Acad. Sci. USA 85: 8439-8443.
44. 44. Stenzel-Poore, M.P., K.A. Heldwein, P. Stenzel et al. 1992. Characterization of the genomic corticotropin-releasing factor (CRF) gene from Xenopus laevis: two members of the CRF family exist in amphibians. Mol. Endocrinol. 6: 1716-1724.
45. 45. Vaughan, J., C. Donaldson, J. Bittencourt et al. 1995. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 378: 287-292.
46. 46. Donaldson, C.J., S.W. Sutton, M.H. Perrin et al. 1996. Cloning and characterization of human urocortin. Endocrinology 137: 2167-2170.
47. 47. Kozicz, T., H. Yanaihara & A. Arimura. 1998. Distribution of urocortin-like immunoreactivity in the central nervous system of the rat. J. Comp. Neurol. 391: 1-10.
48. 48. Yamamoto, H., T. Maeda, M. Fujimura et al. 1998. Urocortin-like immunoreactivity in the substantia nigra, ventral tegmental area and Edinger-Westphal nucleus of rat. Neurosci. Lett. 243: 21-24.
49. 49. Oki, Y., M. Iwabuchi, M. Masuzawa et al. 1998. Distribution and concentration of urocortin, and effect of adrenalectomy on its content in rat hypothalamus. Life Sci. 62: 807-812.
50. 50. Takahashi, K., K. Totsune, M. Sone et al. 1998. Regional distribution of urocortin-like immunoreactivity and expression of urocortin mRNA in the human brain. Peptides 19: 643-647.
51. 51. Wong, M.L., A. Al-Shekhlee, P.B. Bongiorno et al. 1996. Localization of urocortin messenger RNA in rat brain and pituitary. Mol. Psychiatry 1: 307-312.
52. 52. Iino, K., H. Sasano, Y. Oki et al. 1997. Urocortin expression in human pituitary gland and pituitary adenoma. J. Clin. Endocrinol. Metab. 82: 3842-3850.
53. 53. Iino, K., H. Sasano, T. Suzuki et al. 1998. Urocortin expression in mucosal inflammatory cells of human gastrointestinal tract. (Abst. # P2-561). In Endocrine Soc. Meeting, June 1988, New Orleans, Louisiana.
54. 54. Petraglia, F., P. Florio, R. Gallo et al. 1996. Human placenta and fetal membranes express human urocortin mRNA and peptide. J. Clin. Endocrinol. Metab. 81: 3807-3810.
55. 55. Okosi, A., B.K. Brar, M. Chan et al. 1998. Expression and protective effects of urocortin in cardiac myocytes. Neuropeptides 32: 167-171.
56. 56. Bamberger, C.M., M. Wald, A.M. Bamberger et al. 1998. Human lymphocytes produce urocortin, but not corticotropin-releasing hormone. J. Clin. Endocrinol. Metab. 83: 708-711.
57. 57. Poliak, S., F. Mor, P. Conlon et al. 1997. Stress and autoimmunity: the neuropeptides corticotropin-releasing factor and urocortin suppress encephalomyelitis via effects on both the hypothalamic-pituitary-adrenal axis and the immune system. J. Immunol. 158: 5751-5756.
58. 58. Turnbull, A.V., W. Vale & C. Rivier 1996. Urocortin, a corticotropin-releasing factor-related mammalian peptide, inhibits edema due to thermal injury in rats. Eur. J. Pharmacol. 15: 213-216.
59. 59. Smagin, G.N., L.A. Howell, D.H. Ryan et al. 1998. the role of CRF2 receptors in corticotropin-releasing factor-and urocortin-induced anorexia. Neuroreport 9: 1601-1606.
60. 60. Perrin, M.H., S.W. Sutton, L. Cervini et al. 1999. Comparison of an agonist, urocortin, and an antagonist, astressin, as radioligands for characterisation of CRF receptors. J. Pharm. Exp. Ther. 288: 729-734.
61. 61. Gulyas, J., C. Rivier, M. Perrin et al. 1995. Potent, structurally constrained agonists and competitive antagonists of corticotropin-releasing factor. Proc. Natl. Acad. Sci. USA 92: 10575-10579.
62. 62. Perrin, M.H., S. Sutton, D.B. Bain et al. 1998. The first extracellular domain of corticotropin releasing factor-R1 contains major binding determinants for urocortin and astressin. Endocrinology 139: 566-570.
63. 63. Mathews, L. & W. Vale. 1991. Expression cloning of an activin receptor, a predicted transmembrane serine kinase. Cell 65: 973-982.
64. 64. Sydow, S., J. Radulovic, F.M. Dautzenberg et al. 1997. Structure-function relationship of different domains of the rat corticotropin-releasing factor receptor. Brain Res. Mol. Brain Res. 52: 182-193.
65. 65. Qi, L.J., A.T. Leung, Y. Xiong et al. 1997. Extracellular cysteines of the corticotropin-releasing factor receptor are critical for ligand interaction. Biochemistry 36: 12442-12448.
66. 66. Liaw, C.W., D.E. Grigoriadis, T.W. Lovenberg et al. 1997. Localisation of ligand-binding domains of human corticotropin-releasing factor receptor: a chimeric receptor approach. Mol. Endocrinol. 11: 980-985.
67. 67. Liaw, C.W., D.E. Grigoriadis, M.T. Lorang et al. 1997. Localization of agonistand antagonist-binding domains of human corticotropin-releasing factor receptors. Mol. Endocrinol. 11: 2048-2053.
68. 68. Dautzenberg, F.M., S. Wille, R. Lohmann et al. 1998. Mapping of the ligand-selective domain of the Xenopus laevis corticotropin-releasing factor receptor I: Implications for the ligand-binding site. Proc. Natl. Acad. Sci. 95: 4941-4946.
69. 1 receptor antagonist. J. Med. Chem. 39: 4358-4360.
70. 1 receptor antagonists. J. Med. Chem. 39: 4354-4357.
71. 71. Schulz, D.W., R.S. Mansbach, J. Sprouse et al. 1996. CP-154,526: A potent and selective nonpeptiue antagonist of corticotropin releasing factor receptors. Proc. Natl. Acad. Sci. 93: 10477-10482.
72. 72. Webster, W.L., D.B. Lewis, D.J. Torpy et al. 1996. In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation. Endocrinology 137: 5747-5750.